ON DEMAND Webinar: Spotlight on emerging therapies for patients with EGFR-positive NSCLC

Learning objective:         

After watching this webinar, participants should be able to:

• Describe the novel paradigms for TKI resistant disease in advanced NSCLC patients with common EGFR mutations
• Evaluate the unmet needs for advanced NSCLC patients with EGFR exon 20 insertions
• Identify and review the latest advances of the emerging options in these patient populations

Faculty:

• Maria Rosario Campelo (Spain)
• Michael Thomas (Germany)
• Nicolas Girard (France)
• Anne Marie Dingemans (Netherlands)